Cargando…

Comparing the Prognostic Value of PTEN and Akt Expression with the Mitotic Activity Index in Adjuvant Chemotherapy-Treated Node-Negative Breast Cancer patients aged <55 years

Background: The prognostic value of the PI3K/Akt/mTOR pathway and PTEN in invasive breast cancer (IBC) is controversial. Cell proliferation, especially the Mitotic Activity Index (MAI), is strongly prognostic in lymph node-negative (LNneg) invasive breast cancer. However, its prognostic value has no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janssen, Emiel A. M., Søiland, Håvard, Skaland, Ivar, Gudlaugson, Einar, Kjellevold, Kjell H., Nysted, Arne, Søreide, Jon-Arne, Baak, Jan P. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2007
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618432/ https://www.ncbi.nlm.nih.gov/pubmed/17429139 http://dx.doi.org/10.1155/2007/569246

Ejemplares similares

LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
por: Janssen, Emiel A. M., et al.
Publicado: (2009)

Success Predictors of Adjuvant Chemotherapy in Node-Negative Breast Cancer Patients Under 55 years(1)
por: Janssen, Emiel A. M., et al.
Publicado: (2006)

Emerging Concepts of Apolipoprotein D with Possible Implications for Breast Cancer
por: Søiland, Håvard, et al.
Publicado: (2007)

Cell-cycle and Apoptosis Regulators (p16(INK4A), p21(CIP1), α-Catenin, Survivin, and hTERT) and Morphometry-Defined MPECs Predict Metachronous Cancer Development in Colorectal Adenoma Patients
por: Soreide, Kjetil, et al.
Publicado: (2007)

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial
por: Lende, Tone Hoel, et al.
Publicado: (2019)

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer
por: Lillesand, Melinda, et al.
Publicado: (2020)

The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer
por: Skaland, Ivar, et al.
Publicado: (2009)

Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer
por: Jonsdottir, Kristin, et al.
Publicado: (2014)

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers
por: Jonsdottir, Kristin, et al.
Publicado: (2012)

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients — an explorative study
por: Lende, Tone Hoel, et al.
Publicado: (2019)

The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer
por: Klintman, Marie, et al.
Publicado: (2013)

Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index
por: Lea, Dordi, et al.
Publicado: (2021)

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients
por: Egeland, Nina Gran, et al.
Publicado: (2019)

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study
por: Munk, Ane Cecilie, et al.
Publicado: (2012)

Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer
por: Watson, Martin M., et al.
Publicado: (2020)

Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies
por: Uleberg, Kai-Erik, et al.
Publicado: (2011)

A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment
por: Lea, Dordi, et al.
Publicado: (2021)

MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
por: Egeland, Nina Gran, et al.
Publicado: (2020)

A protein profile study to discriminate CIN lesions from normal cervical epithelium
por: Uleberg, Kai-Erik, et al.
Publicado: (2011)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Kruse, Arnold-Jan, et al.
Publicado: (2004)

Adult pancreatic hemangioma in pregnancy – concerns and considerations of a rare case
por: Søreide, Jon Arne, et al.
Publicado: (2015)

TOPK and PTEN participate in CHFR mediated mitotic checkpoint()
por: Shinde, Swapnil R., et al.
Publicado: (2013)

Can Proliferation Biomarkers Reliably Predict Recurrence in World Health Organization 2003 Defined Endometrial Stromal Sarcoma, Low Grade?
por: Feng, Weiwei, et al.
Publicado: (2013)

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
por: Egeland, Nina Gran, et al.
Publicado: (2020)

Hepatoid adenocarcinoma of the stomach – proper identification and treatment remain a challenge
por: Søreide, Jon Arne, et al.
Publicado: (2016)

Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics
por: Oltedal, Satu, et al.
Publicado: (2018)

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
por: Helland, Thomas, et al.
Publicado: (2017)

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients
por: Egeland, Nina G., et al.
Publicado: (2015)

CBX8 interacts with chromatin PTEN and is involved in regulating mitotic progression
por: Choi, Byeong Hyeok, et al.
Publicado: (2021)

PTEN is a negative regulator of mitotic checkpoint complex during the cell cycle
por: Choi, Byeong H., et al.
Publicado: (2017)

Therapeutic Approaches to Gastric Hepatoid Adenocarcinoma: Current Perspectives
por: Søreide, Jon Arne
Publicado: (2019)

Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
por: Helland, Thomas, et al.
Publicado: (2020)

Scoring systems for outcome prediction in patients with perforated peptic ulcer
por: Thorsen, Kenneth, et al.
Publicado: (2013)

What Is the Best Predictor of Mortality in Perforated Peptic Ulcer Disease? A Population-Based, Multivariable Regression Analysis Including Three Clinical Scoring Systems
por: Thorsen, Kenneth, et al.
Publicado: (2014)

PTEN suppresses tumorigenesis by directly dephosphorylating Akt
por: Bu, Lang, et al.
Publicado: (2021)

circPTEN suppresses colorectal cancer progression through regulating PTEN/AKT pathway
por: Li, Chen, et al.
Publicado: (2021)

DNA replication and mitotic entry: A brake model for cell cycle progression
por: Lemmens, Bennie, et al.
Publicado: (2019)

Spatial regulation of Cdc55–PP2A by Zds1/Zds2 controls mitotic entry and mitotic exit in budding yeast
por: Rossio, Valentina, et al.
Publicado: (2011)

The decision to enter mitosis: feedback and redundancy in the mitotic entry network
por: Lindqvist, Arne, et al.
Publicado: (2009)

Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity
por: Lindberg, Karolina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mmkbsundmd4ja9llcuq9k82jq5